MDA Ltd.
MDALF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.73 | 0.35 | 0.03 | -3.67 |
| FCF Yield | 17.05% | -12.76% | -16.78% | -1.82% |
| EV / EBITDA | 15.54 | 12.41 | 6.53 | 10.66 |
| Quality | ||||
| ROIC | 5.02% | 3.12% | 3.99% | 0.36% |
| Gross Margin | 26.08% | 30.21% | 35.62% | 35.19% |
| Cash Conversion Ratio | 10.27 | 0.28 | 2.17 | 6.38 |
| Growth | ||||
| Revenue 3-Year CAGR | 18.98% | 19.19% | 29.45% | 7,812,743.18% |
| Free Cash Flow Growth | 442.13% | -45.98% | -447.11% | -152.20% |
| Safety | ||||
| Net Debt / EBITDA | -0.13 | 3.26 | 1.47 | 0.62 |
| Interest Coverage | 3.81 | 9.01 | 2.16 | 0.58 |
| Efficiency | ||||
| Inventory Turnover | 98.57 | 56.93 | 55.04 | 38.64 |
| Cash Conversion Cycle | 18.42 | 9.82 | 74.10 | 70.21 |